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Sex impacts on liver physiology with severe conse-
quences for energy metabolism and response to
xenobiotic, hepatic, and extra-hepatic diseases.
The comprehension of the biology subtending sex-
related hepatic differences is therefore very rele-
vant in the medical, pharmacological, and dietary
perspective. The extensive application of metabolo-
mics paired to transcriptomics here shows that, in
the case of short-term fasting, the decision to main-
tain lipid synthesis using amino acids (aa) as a source
of fuel is the key discriminant for the hepatic meta-
bolism of male and female mice. Pharmacological
and genetic interventions indicate that the hepatic
estrogen receptor (ERa) has a key role in this sex-
related strategy that is primed around birth by the
aromatase-dependent conversion of testosterone
into estradiol. This energy partition strategy, possibly
the result of an evolutionary pressure enabling mam-
mals to tailor their reproductive capacities to nutri-
tional status, is most important to direct future sex-
specific dietary and medical interventions.
INTRODUCTION
The liver appears to be one of the organs functionally most
affected by sex, and increasing evidence shows fundamental
differences in the utilization of lipids and carbohydrates as a
source of fuel in male and female mammals (Mauvais-Jarvis,
2015). The current paradigm is that at rest females tend to syn-
thesize fatty acids (FAs) and triglycerides (TGs) to be stored as
fat, and in contrast, males oxidize FAs; during exercise, women,
in overt opposition to men, were reported to utilize more lipids
than carbohydrates (Horton et al., 1998; Mauvais-Jarvis, 2015;
Uranga et al., 2005). This strategy in energy partitioning was
proposed to be a consequence of the respective sexual role.
Females would be able to stock the energy necessary to main-
tain the reproductive capacities during periods of limited foodCell Metabolism 28, 1–12,
This is an open access article under the CC BY-Nshortage and, in due time, to spare the glucose and proteins
necessary for the growth of the fetus by mobilizing the energy
stores. In males it would provide a large source of energy for
muscle activity (Mauvais-Jarvis, 2015).
These physiological differences impact significantly on the sex
prevalence of hepatic and extra-hepatic diseases such as fatty
liver and non-alcoholic fatty liver disease, metabolic syndrome,
atherosclerosis, diabetes, and others that are more predominant
in men (Arnold et al., 2017; Ayonrinde et al., 2011; Della Torre
et al., 2014; Della Torre and Maggi, 2017; Kautzky-Willer et al.,
2016; Mauvais-Jarvis, 2015; Regitz-Zagrosek and Kararigas,
2017; Spence and Pilote, 2015); because of that, sex metabolic
differences would deserve a better understanding of the under-
lying molecular mechanisms that remain largely unidentified.
Indeed, initial studies that applied the power of transcriptomics
and genetics further stressed male-female differential use of
lipids and carbohydrates and pinpointed some of the molecular
pathways involved. The transcriptomic profiling and biochemical
analyses in rodents indicated that about 10% of the transcrip-
tionally active genes in the liver have a sex-dependent expres-
sion; transcripts for the synthesis of triglycerides, cholesterol,
and very-low-density lipoprotein (VLDL) particles were more ex-
pressed in females while genes for FA oxidation, gluconeogen-
esis, and glycogen synthesis were predominant in males, further
stressing the tendency of females to privilege lipid synthesis and
males to create large glycogen stores (Hagve and Christo-
phersen, 1986; Ivey and Gaesser, 1987; Kushlan et al., 1981;
Lorbek et al., 2013; Mauvais-Jarvis, 2015; Price and Sanders,
2017; Tarnopolsky and Ruby, 2001). Experiments done with mu-
tants of PPARa (the master regulator of FA oxidation) showed
that in PPARa/ mice the pharmacological inhibition of FA
oxidation leads to lipid accumulation and death for hypoglyce-
mia mainly in males, while only 25% of females undergoing the
same treatment die because of their major ability to oxidize
FAs even in the absence of the PPARa receptor (Djouadi
et al., 1998).
Very little is known with regard to protein metabolism in the
liver and to the existence of sex-dependent mechanisms con-
trolling amino acid (aa) utilization in the overall energy production
by hepatic cells. Yet, hepatic aa appear to be deeply involved in
female reproductive physiology. In fact, aa were described to
play a major role in the maintenance of the reproductive cycleAugust 7, 2018 ª 2018 The Author(s). Published by Elsevier Inc. 1
C-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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of aa in the initial phases of pregnancy is associated with the pro-
duction of lipids to be accumulated in the maternal fat stores; in
late pregnancy, the liver is responsible for the shift from the
anabolic to a catabolic state that promotes the use of lipids as
a maternal energy source while preserving glucose and aa for
the fetus (Butte, 2000). In addition, our previous observations
showed that female liver metabolism is highly influenced by the
activity of hepatic ERa and that, together with estrogens, aa
are able to activate transcriptionally ERa, suggesting that also
aa intracellular signaling may play a role in differentiating the
physiological activities of female and male livers (Della Torre
et al., 2011).
The aim of our study was therefore to exploit the combined
power of metabolomics and transcriptomics to get a compre-
hensive insight on male and female liver metabolic strategies.
Our results here show a major sexual dimorphism in the use of
aa as source of fuel for the production of lipids. Interestingly, in
both males and females the hepatic ERa plays a key role in
such a selection; in females, the lack of ERa expression reduces
significantly the use of aa as a source for lipid synthesis and the
production of NADPH through the pentose phosphate pathway
(PPP), while the opposite is true in males where the ERa repre-
sents a break for the use of aa to feed the tricarboxylic acid cycle
(TCA). These sex-specific metabolic features appear to be im-
printed around birth and are not observed in muscle and adipose
tissues.
RESULTS
Liver Transcriptome Profiling Reveals a Sex-Biased
Response to Short-Term Fasting
Prior experimentation demonstrated that, in female mammals,
the phase of the estrous cycle has a significant impact on liver
transcriptome (Della Torre et al., 2016; Villa et al., 2012), there-
fore the initial comparative study was carried out in females in
two phases of the cycle characterized by high and low circulating
estrogens (proestrus, P, and metestrus, M, respectively). All ex-
periments were done with littermates and mice were euthanized
after 6 hr of fasting, because it is known that food intake activates
the hepatic estrogen receptor transcriptionally (Della Torre
et al., 2011).
By considering a fold change > 1.5 and a false discovery rate <
0.01 we found that the sex-dependent differential expression
engaged 1,120 genes with females at M and 859 at P. Of rele-
vance, only 497 (<35%) were in common between P and M (Fig-
ure S1A). We next examined the extent of expression of the
differentially regulated genes (DEGs) and, once more, the great-
est differences were observed between males and females at M
(Figure S1B). These findings led us to continue the study with fe-
males at M.
The male/female-M comparative study indicated that 8.7% of
all the genes expressed in the liver was sexually differentiated;
out of those, 5.2% of the genes was upregulated in females
and 3.5% in males (Figures 1A and 1B). Cluster analysis of the
networks related to the DEGs showed that the large majority of
the genes upregulated in males was associated with the inhibi-
tion of gluconeogenesis, while fewer genes were encoding pro-
teins for the regulation of nucleic acid and protein catabolism2 Cell Metabolism 28, 1–12, August 7, 2018(Figure 1C). Conversely, the effect of fasting appeared to be
very different in females where we found the upregulated genes
involved in a large variety of metabolic pathways (Figure 1D).
Amore detailed analysis based on themost relevantmetabolic
pathways indicated that, in female liver, there was an upregula-
tion of specific mRNAs encoding enzymes for the gluconeogen-
esis, PPP and TCA (Figure 1E), and a strong overexpression of
mRNAs for the synthesis of FAs and TGs (Figure 1F). In line
with a metabolism geared toward lipid synthesis, we found
that several of the mRNAs associated with the negative regula-
tion of gluconeogenesis and lipogenesis were significantly less
expressed in females (Figure S1C). At the same time, in the fe-
male group we observed higher expression of genes encoding
enzymes for amino acid (aa) metabolism, transport (Figure 1G)
and detoxification (urea cycle) (Figure S1D), with lower amounts
of protease and peptidase inhibitors (Figure S1E). These findings
suggested that, in response to a mild fasting females, unlike
males, synthesized lipids, possibly by depleting the proteins pre-
sent in the liver.
Liver, but Not Fat and Muscle, Shows a Sexually
Dimorphic Response to a Short-Time Fasting
To better understand the physiological relevance of the sex-
related differences found, we proceeded with the quantitative
measurement of the biologically most relevant metabolites pre-
sent in the liver. In keeping with the transcriptomic study, the
heatmap of liver metabolites (Figure 2A) pointed to major meta-
bolic differences in the two sexes, further highlighted by prin-
cipal-component analysis (PCA) (Figure 2B). In particular, in fe-
male liver we found a higher content of selected metabolites
of the glycolytic/gluconeogenic pathways (glucose-6-phos-
phate and pyruvate), PPP (ribulose-5-phosphate and erythrose
4-phosphate), TCA cycle (citrate, a-ketoglutarate, fumarate,
and malate), and lipogenesis (malonyl-CoA) (Figures 2C, 2D,
and S2A; Table S1). The higher content of malonyl-CoA,
together with the remarkable expression of the lipogenic genes
(Figure 1F), the lower NADP+/NADPH ratio, and the higher en-
ergy charge values (Figures 2E and S2B), suggested that fe-
males favored lipid synthesis. The measurement of liver TGs
confirmed such a hypothesis showing that the content of TGs
in female liver was higher than in males (+150%; Figure S2C).
Finally, the low aa content reinforced the findings of the tran-
scriptomics that suggested the use of aa to sustain the TCA
cycle anaplerosis (Figures 2F and S2A) in the absence of
increased FA oxidation as highlighted by acyl-carnitine levels
(Figure 2G). Unsupervised bioinformatics studies based on me-
tabolomics pathway and fold enrichment analysis (Figures
S2D–S2F), together with the integrated analysis of transcrip-
tomic and metabolomic data (Figures S2G–S2I), further indi-
cated that female liver preferentially used aa to synthetize lipids
even if under a short-time fasting. All these data suggested the
existence of a sex-specific strategy for the regulation of liver
metabolism in case of a starvation limited in time: male livers
were still in a steady state, while females were engaged in aa uti-
lization to fuel the TCA cycle and gluconeogenesis, and to
ensure the production of lipids.
The question to be raised at this point was to which extent the
sex differences observed were a peculiarity of the liver or repre-
sented a general feature of female metabolism. This led us to
Figure 1. Liver Transcriptome Shows a Sex-
Specific Metabolic Response to Short-Term
Fasting
(A) Sexually dimorphic gene expression obtained
by RNA sequencing (RNA-seq) analysis performed
in the liver of males and females at metestrus (M)
(fold change, jFCj > 1.5 and false discovery rate
[FDR] < 0.01).
(B) Volcano plot of all detectable genes: female/
male ratio of gene expression (FC) is shown on the
x axis as Log2 and significance is displayed on the
y axis as Log10 of the adjusted FDR. Genes with
significantly upregulated expression in males and
females are colored in blue and red, respectively;
genes without gender bias are displayed in gray.
(C and D) Cluster analysis of functional networks
significantly enriched in the liver of males (C) and
females at M (D). Only the most significant term per
group is labeled.
(E–G) Heatmaps reporting as Log2 fold change the
expression of genes involved in glycolysis (Glyc),
gluconeogenesis (Gluc), PPP, and TCA (E), FA and
TG synthesis (F), and aa metabolism and aa
transport (G) from RNA-seq analysis performed in
the livers of males and females at M. Only genes
with an FDR < 0.05 are considered.
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muscle and white adipose tissue (WAT). The heatmap profiles
showed in Figures 3A and 3C indicated that in the two sexes
both muscle and WAT had reacted very similarly to the short-
time fasting. The hierarchical clustering of the 12 animals studied
(six females and six males) did not enable to group each meta-
bolic profile with regard to sex and the PCA analyses gave pat-
terns largely overlapping in the two sexes (Figures 3B and 3D).
These observations demonstrated the absence of a sex-related
control mechanism of muscle and adipose metabolism that
could be triggered by our experimental conditions.
Conversely, metabolite analysis in male and female gonads
and their hierarchical clustering showed well-distinguishedCmetabolic profiles. Compared with male
(testis), female gonads (ovary) were char-
acterized by the low content of metabo-
lites of the glycolytic/gluconeogenic path-
ways and aa metabolites and a large
content of acyl-carnitines, possibly indi-
cating that also in the gonads female
metabolism is geared toward aa utiliza-
tion, while males tend to spare these sub-
strates (Figure 3E). This sex-specific
metabolism was further emphasized by
PCA, which discriminated very well the
data obtained in ovaries and testes
(Figure 3F).
Thus, among the investigated organs
not strictly responsible for reproductive
functions, the liver appeared to have a
unique ability to respond to the selected
metabolic challenge in a sex-differenti-
ated manner, and this led us to furtherinvestigate whether such a sexual identity was fixed during
development.
Is the Liver a Sexually Differentiated Organ?
In mammals sexual differentiation initiates during embryo devel-
opment and continues until after puberty driven by a combina-
tion of genetic and hormonal events. Early in embryogenesis,
the product of the sex-determining gene (Sry) in the Y chromo-
some leads to the differentiation of male gonads. Following
that, there is a perinatal surge of testicular activity (in rodents
the first testosterone surge is in the late gestational period and
the second peak occurs at the immediate postnatal time) (Corb-
ier et al., 1992; Konkle and McCarthy, 2011; Clarkson andell Metabolism 28, 1–12, August 7, 2018 3
Figure 2. Metabolic Profiling Shows Female
Propensity to Use aa to Synthesize Lipids in
Short-Time Fasting
(A) Hierarchical clustering heatmap of biologically
major metabolites of the Glyc/Gluc, PPP, TCA,
energy metabolism (En. Met.), aa, and acyl-carni-
tines (Acyl-Carn) measured in the liver of males
(left, marked by the blue bar) and of females at
M (right, marked by red bar). The color-coded
scale on the left indicates the normalized metab-
olite expression.
(B) Score plot of a principal-component analysis
(PCA) of the data shown in (A) done using
MetaboAnalyst 3.0 software. Colored ellipses
represent 95% confidence intervals and highlight
the basic clustering/separation between groups.
Colored dots represent individual samples (n = 6).
(C–E) Quantitative analysis of liver metabolites
belonging to Glyc/Gluc and PPP (C), TCA (D), and
energy metabolism (E). Bars are mean ± SEM
(n = 6). *p < 0.05, **p < 0.01, ***p < 0.001 by t test.
(F and G) aa (F) and acyl-carnitines (G) quantitative
analysis in the liver of males and females at M. Bars
are mean ± SEM (n = 6). *p < 0.05, **p < 0.01 by
t test.
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organizational effects that predispose tissues other than the go-
nads to be ‘‘activated’’ at puberty by sex hormones (Mauvais-
Jarvis et al., 2017). This phenomenon is well described and ex-
plains the changes driving the secondary sex characteristics.
This organizational effect has been largely investigated in the
brain where the high content of aromatase was described to
convert circulating testosterone into estradiol; this latter hor-
mone is responsible for the ‘‘masculinization’’ of neural circuits
that become permissive to the activation of male functions and
behaviors at puberty (Arnold and Gorski, 1984; Gorski and Wag-
ner, 1965).
On this backgroundknowledge,weaskedwhether such testos-
terone/estradiol-induced differentiation occurred also in the liver4 Cell Metabolism 28, 1–12, August 7, 2018and we set up a series of experiments
aimed at testing this hypothesis. First, we
evaluated the extent to which liver is sexu-
ally differentiated in the neonates. Differ-
ently from that seen in the adults, PCA
analysis obtained from the metabolic
signature of livers from female and male
mice at postnatal day 1 (P1) (Figure 4A)
showed partially overlapping ellipses, indi-
cating the potential for some sexual differ-
entiation. Indeed, when we prevented liver
masculinization (Plourde et al., 1995) by
treating the pregnant mothers and the
pupswith the aromatase inhibitor Arimidex
(which precluded the perinatal synthesis of
estradiol from testosterone) the PCA of
liver metabolites was completely superim-
posable in the two sexes. This provided an
initial evidence that testosterone conver-
sion into estradiol was a prerequisite forliver sexual differentiation. Consistent with that, unsupervised
clustering analysis of hepatic metabolites failed to discriminate
between males and females (Figures 4B and S3).
To further evaluate the extent to which testosterone conver-
sion into estradiol was relevant for male liver differentiation, we
measured the metabolites of the livers of adult (3-month-old)
aromatase KO mice (ArKO) (see STAR Methods). No significant
differences were found (Figures 4C–4E), suggesting that the
metabolic sexual dimorphism of liver might have been driven
by estrogens.
Finally, we attempted to masculinize female livers by treating
genetically female mice with estradiol-benzoate (50 mg/kg) or
vehicle at P2, P5, and P8. The metabolomic study was then
done in the livers of adult animals. The results in Figure 5A
Figure 3. Male and Female Mice Have a
Very Similar Muscle and WAT Metabolic
Profile
(A and B) Hierarchical clustering heatmap (A) and
score plot of PCA (B) of muscle from males and
females at M (n = 6).
(C and D) Hierarchical clustering heatmap (C) and
score plot of PCA (D) of white adipose tissue (WAT)
from males and females at M (n = 6).
(E and F) Hierarchical clustering heatmap (E) and
score plot of PCA (F) of the reproductive tissues
from males (testis) and females at M (ovary)
(n = 6).
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sex-specific metabolic profile, as indicated by the low content of
metabolites relevant for the gluconeogenic and PPP pathways
and by the relatively high content of aa (which, in the estrogen-
treated females, was generally indistinguishable from males).
Less obvious was the effect of estrogen treatment on the TCA
cycle and energy metabolites. As expected, the same treatment
carried out in parallel in males did not induce any significant
metabolic alteration (Figure 5A).
This set of experiments clearly demonstrated that in females
the perinatal exposure to estradiol induced permanent changes
in liver metabolic profile.CWe therefore investigated the ability
of neonatal liver to aromatize circulating
testosterone by collecting the livers at
different developmental stages (E18.5,
P0, P1, P8, P20, P40, and P50) to mea-
sure Cyp19a1 gene expression. In both
sexes, at no time point we could detect
the mRNA encoded by the aromatase
gene (data not shown); this ruled out
the hypothesis of a local testosterone
conversion. Yet, when we measured
luciferase activity at P1 in the ERE-Luc
reporter mouse (Ciana et al., 2001),
the reporter content in the liver was
much higher in males than in females
(Figure 5B); the male-specific increase
of luciferase accumulation observed at
P1 in the liver was similar to that found
in the sexually dimorphic brain, but not
in other organs where sexual differenti-
ation has not been reported, such as
the intestine, lung, or thymus (Fig-
ure S4A). This showed that in males
the ERa was transcriptionally active at
the time of neonatal sexual differentia-
tion. In agreement with this finding,
Esr1 mRNA was significantly higher
in the male livers at birth, where
the expression of the receptor kept
increasing up to day 8 to then decrease
to reach the low levels characteristic of
adult males (Della Torre et al., 2016)
(Figure 5C). Conversely, in both sexesandrogen receptor (Ar) mRNA was little expressed prior to
birth up to P8 (Figure 5D). This observation, together
with the fact that, in liver at E18.5, P0, and P1, Esr1 was
6–7 times more expressed than Ar (data not shown), led us
to conclude that AR was unlikely to be engaged in the pro-
cess of liver masculinization while the liver ERa was clearly
involved.
Next, to verify that estrogens could be synthetized in organs
different from the liver, we measured aromatase expression in
male testis. As shown in Figure S4B, the amount of Cyp19a1
mRNA in the testis is comparable with what found in male brain
at the same age.ell Metabolism 28, 1–12, August 7, 2018 5
Figure 4. Sex-Specific Liver Metabolome
Is Associated with Neonatal Estrogen
Signaling
(A and B) PCA (A) and hierarchical clustering
heatmap (B) measured at P1 in the liver of males
and females treated with vehicle (VEH) or 1 mg/kg
Arimidex (Ar).
(C–E) Quantitative analysis of the metabolites
measured in the liver of 3-month-old adult male
and female ArKO (aromatase KO) mice. Data
represent mean ± SEM (n = 3).
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To finally demonstrate the role of the hepatic ERa in sustaining
liver sexual dimorphism, we carried out a liver-specific deletion
of the Esr1 gene using a Cre-LoxP recombination system where
the Cre-recombinase was driven by the albumin promoter
(LERKO mice) (Della Torre et al., 2011). The RNA sequencing
(RNA-seq) study demonstrated that in the liver of adult LERKO
mice the Esr1 gene expression was significantly decreased (Fig-
ure 6A). To have direct insight on the timing of ERa deletion in the
liver of the LERKOmutants generated, wemeasured Esr1mRNA
at different developmental times. The presence of the Cre-re-
combinase prevented the synthesis of Esr1 mRNA already at
E18.5 in both sexes (Figure 5C). Thus, an impairment of liver peri-
natal masculinization should have occurred in LERKO males.
The elimination of ERa did not affect the expression of the AR
up to day P40, but appeared to limit significantly the expression
of this gene in the adult males (Figure 5D).
With regard to general metabolic parameters, the LERKO mu-
tation did not affect body and WAT weight; however, food intake
was increased in the male LERKO only; this augmented food
intake in the absence of an increased body weight was indicative
of some metabolic alterations that limited feed efficiency
(Figure S4C).6 Cell Metabolism 28, 1–12, August 7, 2018Transcriptome investigation showed
that in LERKO liver sex differences
were maintained for 42% of the genes
(Figures S4D and S4E). Gene ontology
analysis, however, did not allow us to
pinpoint metabolic strategies character-
istic of the LERKO mutants (Figures
S5A and S5B), and this induced us to
continue with the metabolic study. In
spite of the fact that PCA (Figure 6B)
and hierarchical clustering (Figure 6C)
showed a good degree of maintenance
of liver sexual identity in the LERKO mu-
tants, the neonatal ERa ablation had a
significant impact on aa metabolism of
adult males as indicated by the hepatic
content of aa that was reduced to levels
comparable with control females (Fig-
ure S6A). Yet, different from control fe-
males, in the LERKO male livers the aa
did not appear to give a significant
contribution to the TCA anaplerosisand, more importantly, to the gluconeogenesis or lipid syn-
thesis (Figure S6B). This was also indicated by the very
limited increase of the enzymes necessary for lipid synthesis
(Figure 6G) and the lack of lipid accumulation in the hepatic
parenchyma (Figure 6I). This was ascribed to the fact that
male LERKO lacked the circulating estrogens and hepatic
ERa necessary to direct the metabolism toward the female
phenotype.
In females, ERa ablation caused a generalized increase in
liver content of aa, particularly significant for Ser, Thr, and Gln
(Figure S6A), potentially ascribable to a reduced aa catabolism
and transport (Figure 6D). With the exception of citrate (that was
significantly decreased), TCA intermediates (Figure S6B) and
the related genes (Figure 6E) were unaffected by the mutation.
The increased expression of the mitochondrial phosphoenol-
pyruvate carboxykinase 2 (Pck2) (Figure 6F) together with the
low content of pyruvate and the still high content of oxaloace-
tate (Figure S6B) indicated that, possibly, LERKO females
used lactate as a preferential substrate instead of aa as a source
for gluconeogenesis. This change in the metabolic strategy
might enable LERKO females to pursue the synthesis of lipids
(Figure 6G). The significantly increased content of TGs (Fig-
ure 6I) in LERKO female liver was likely the result of a reduced
TG secretion and of an increased lipid uptake, as suggested
(legend on next page)
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Figure 6. Liver Metabolic Consequences of
Esr1 Gene Ablation
(A) Heatmap of Esr1 expression in the liver of
control (ERa floxed mice, CTRL) and LERKO (liver
ERa KO mice) males and females at M and at P as
measured by RNA-seq.
(B and C) Score plot of PCA (B) and hierarchical
clustering heatmap (C) of biologically relevant
metabolites measured in the liver of males (MAL),
LERKO males (LERKO MAL), females (FEM), and
LERKO females (LERKO FEM) (n = 6).
(D–H) Heatmap reporting as Log2 fold change the
mean expression of genes involved in aa meta-
bolism (D) (upper), aa transport (D) (lower), TCA (E),
glycolysis (F) (upper), gluconeogenesis (F) (lower),
synthesis of FA (G) (upper) and TG (G) (lower), TG
secretion and uptake (H) from RNA-seq analysis
performed in the livers of males, females, LERKO
males and LERKO females.
(I) Free fatty acids (FFA), triglyceride (TG), and
cholesterol (CH) content measured in the livers of
control and LERKO males and females at M. The
data are mean ± SEM (n = 10–14). *p < 0.05, **p <
0.01, and ***p < 0.001 versus MAL; ###p < 0.001
versus control mice.
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Finally, in the liver of LERKO females we observed increased
amounts of medium chain acyl-carnitines (C8-C10) (Figure S6C)Figure 5. Estrogen Signaling in Neonates Masculinizes their Liver Metabolism
(A) Relative analysis of the relevant metabolites measured in the liver of adult male and female mice treated p
estradiol-benzoate (E2). Bars are mean ± SEM (n = 4–12). *p < 0.05, **p < 0.01, ***p < 0.001 versus MAL; #p <
followed by Bonferroni post hoc test.
(B) Luciferase enzymatic activity measured in the liver of male and female mice at embryonal day 16.5 (E1
(n = 2–11). ***p < 0.001 by two-way ANOVA followed by Bonferroni post hoc test.
(C and D) The Esr1mRNA (C) and ArmRNA (D) contents weremeasured by real-time PCR in the liver of males
and LERKO females (LERKO FEM) at different developmental stages (E18.5, P0, P1, P8, P20, P40, and P50). D
versus MAL; #p < 0.05, ##p < 0.01 versus control mice by two-way ANOVA followed by Bonferroni post ho
8 Cell Metabolism 28, 1–12, August 7, 2018that suggested an impairment of FA
b-oxidation despite an increased carni-
tine palmitoyltransferase I (Cpt1a) activ-
ity (Figure S6D). The reduced flux of aa
in the TCA cycle and impaired FA
b-oxidation are in line with a reduced en-
ergy charge in LERKO females (Figures
S6E–S6G). All these features further
contributed to an altered liver meta-
bolism and lipid deposition.
All of these changes in females under-
lined the major metabolic role that the
ERa has in adult female liver.
Finally, we measured the effects of the
LERKO mutation in plasma (Figure S7).
No major alterations were observed,
most of them were associated with males
where plasma concentrations of glucose
and lactate were lower than in the floxed
mice, but identical to females. Ala, Met,and Tyr concentrations were low in the LERKO males; however,
the minimal alterations in plasma aa content suggested that the
liver is the first tissue able to adapt to short-time fasting in a sex-
specific mode.ostnatally (at P2, P5, and P8) with VEH or 50 mg/kg
0.05, ###p < 0.001 versus VEH by two-way ANOVA
6.5), E18.5, and P1. Data represent means ± SEM
(MAL), females (FEM), LERKOmales (LERKOMAL),
ata represent mean ± SEM (n = 4). ***p < 0.001 FEM
c test.
Figure 7. A Comprehensive View of Female
Liver Metabolism When Fasted for a Short
Period of Time
The combined transcriptome and metabolome
analyses enable us to understand the response of
hepatic metabolism of adult females to short
fasting. The metabolites/genes more/less ex-
pressed than in males are shown in red or blue,
respectively. The metabolites/genes equally ex-
pressed in the two sexes are shown in gray.
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This study, by combining transcriptomic and metabolomic data,
shows that the use of aa is a key element to discriminate male
and female hepatic metabolism. In fact, when littermates were
subjected to a metabolic challenge such as short-term fasting,
males preserved liver aa by restraining lipogenic and gluconeo-
genic pathways; on the contrary, females utilized the aa pool. As
comprehensively shown in Figure 7, aa were used for the anaple-
rosis of the TCA cycle and the production of the intermediates
necessary for the gluconeogenic and lipogenic pathways. Inter-
estingly, in these females the gluconeogenic pathway did not
appear to generate glucose only to maintain euglycemia, but
also to employ part of the glucose 6-phosphate made to synthe-
size the metabolites necessary to feed the PPP in order to obtain
the NADPH required for FA anabolism.
Thus, the immediate reaction of female liver to fasting was to
use its available sources to continue in the production of re-
serves in the form of lipids. This female-specific feature seemed
particularly pronounced at metestrus, a phase of the reproduc-
tive cycle where females necessitate cholesterol to initiate ste-
roidogenesis, to build up the energy stores necessary to ovulate
and to prepare the entire organism for potential pregnancy
(Butte, 2000; Miller and Bose, 2011; O’Sullivan, 2009; O’Sullivan
et al., 2001). Such a metabolic response to short-term fasting
was liver specific as neither WAT nor muscle showed any meta-
bolic dimorphism in our experimental conditions. These findings
are consistent with the ancestral and strict functional association
between the liver and the gonads (Della Torre et al., 2014; Della
Torre and Maggi, 2017), where female liver is a primary sensor of
the changes characterizing each reproductive stage (puberty,
ovulation, early and late pregnancy, and lactation), and is the first
organ to adapt its metabolism to female reproductive needs. The
liver, in turn, as a major endocrine organ, may be responsible forCthe production of hormones able to signal
to the other organs (principally the brain,
but also the gonads) the metabolic/func-
tional changes necessary to favor fertility,
gestation, and lactation (e.g., lipids, trans-
port proteins, peptides such as insulin-
like growth factor 1 [IGF-1], fibroblast
growth factor 21 [FGF21], leukocyte cell-
derived chemotaxin-2 [LECT2], and
growth differentiation factor 15 [GDF15])
or other hepatokines identified in our
analyses of the transcriptome (data not
shown) and known to participate in liver-gonad interactions (Della Torre et al., 2011; Runchey, et al.,
2014; Della Torre and Maggi, 2017; O’Rahilly, 2017; Meex and
Watt, 2017).
The existence of a sexual dimorphism in liver has been
described previously and proposed to be the resultant of a
gonadal-hypothalamus-pituitary-liver axis (Mode and Gustafs-
son, 2006). According to this hypothesis, the sex-dependent
pattern of the pituitary growth hormone secretion neonatally im-
printed and emerging at puberty would establish and maintain
the sexually dimorphic liver gene transcription. While we do
not rule out the contribution of such a mechanism to some of
the sex-specific metabolic functions of the adult liver, the results
of the present study show that liver sexual differentiation is
measurable already at P1, and the male-female metabolic differ-
ences are completely abolished by the perinatal treatment with
an aromatase inhibitor. At the same time, the concentration
and transcriptional activity of ERa in male liver is significantly
higher than in female pointing to a direct involvement of the he-
patic ERa in the neonatal liver masculinization.
As aromatase is not present in the mouse liver at birth, it re-
mains to be understood how, in the neonate, hepatic ERa is acti-
vated. Themost likely hypothesis is that the testosterone synthe-
sized by the male gonads is converted into estradiol in organs
other than the liver and then reaches the hepatic parenchyma
via the bloodstream. Supporting this, we showed that testos-
terone aromatization may occur in the male testis where the aro-
matase gene is expressed at P1. This finding is in agreement with
prior literature (Borday et al., 2013). Considering that the liver is
the organ that drains circulating steroids for their catabolism, it
is conceivable that plasma estradiol is able to reach a concentra-
tion sufficient to activate the hepatic ERa.
The extent and the nature of the epigenetic changes induced
perinatally in the liver by testosterone/estradiol remain to be
elucidated, certainly the Esr1 gene and the estrogen signalingell Metabolism 28, 1–12, August 7, 2018 9
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phenotype. In adult mice the expression of the hepatic ERa is
sexually dimorphic; furthermore, during the female reproductive
cycle, both the expression and activity of the hepatic ERa
changes significantly to orchestrate liver metabolism in support
of the progression of the cycle (Della Torre et al., 2016; Villa
et al., 2012). The mutual regulation among liver ERa, hepatic
metabolism, and reproductive functions (Della Torre et al.,
2011, 2016; Villa et al., 2012) might reach its maximum degree
of complexity during pregnancy, when hepatic ERa is likely
involved in regulating the anabolic to catabolic shift of meta-
bolism necessary to sustain the energetic needs of the devel-
oping embryo (Butte, 2000).
The present study highlights aa as the molecular element dis-
tinguishing male and female metabolism: the lack of masculiniza-
tion in ArKOmalemicewas shown to align the content of aa in the
two sexes; conversely, estrogen-masculinized females showed
aa concentrations indistinguishable from males. In the LERKO
mice not all findings had been anticipated: as expected in males
we observed decreased levels of aa due to the impairment of the
masculinization process associated with liver ERa ablation in ne-
onates, while the increased aa concentrations found in females
were unanticipated because the liver has a feminine metabolism
by default. We believe that these results may be ascribed to a
defective metabolism in the adult animals caused by the lack of
ERa, the key female hepatic regulator of metabolism.
To this regard, it is important to consider that liver ERa activity
is transcriptionally regulated by estrogens and aa (Della Torre
et al., 2011). This dual control might be instrumental to differen-
tiate liver ERa-dependent signaling pathways in relation to endo-
crine and nutritional elements. In our previous studies we
demonstrated that hepatic ERa has a key role as a sensor of
nutritional and gonadal signaling and as a regulator of themolec-
ular elements essential for the progression of the reproductive
cycle (e.g., lipids, transport proteins, and IGF-1) (Della Torre
et al., 2011, 2016). Indeed, in case of calorie restriction it was
shown that female mice expressing liver ERa were able to
continue the cycle for a longer time than LERKO, possibly
because of their more efficient use of dietary and liver aa (Della
Torre et al., 2011).
The role of liver in preserving the indissoluble bond between
metabolic and reproductive functions is deeply rooted in phylo-
genesis. In oviparous, the gonads, through the synthesis of spe-
cific hormones, direct liver metabolism toward the synthesis of
the molecules necessary for the maturation of the egg; in turn,
the liver regulates ovarian ovulation in relation to the nutritional
supply (Della Torre et al., 2014; Della Torre and Maggi, 2017).
Conceivably, to bear gestation, female mammals had to further
refine the mechanisms necessary to cope with dietary restric-
tions with the mutable energy requirements associated with
each reproductive phase. Our study shows that, when con-
fronted with the lack of food, the initial strategy of female liver
is to keep building up energy stores (lipids) using the available
aa. This may be highly strategic because of the incapacity of
mammals to synthesize specific aa; by maintaining low levels
of aa, the female liver could keep gauging the nutritional status.
In addition, a liver able to use up all aa available could generate
the lipids to complete ovulation in case of short-time starvation.
In case of a prolonged starvation, the lack of aa would be a very10 Cell Metabolism 28, 1–12, August 7, 2018strong signal for the blockade of all reproductive functions, while
the lipid stored would keep the mother alive. It is not surprising
that such a hepatic mechanism could have been favorably
selected in the past 120 million of years since mammals first ap-
peared on earth. Likely this determined female and male hepatic
metabolism to diverge as males were not subjected to such an
evolutionary pressure.
Lifestyle, obesity, and the control of energy homeostasis are
believed to be central to the ever-growing number of chronic,
non-communicable diseases. The liver with its central role in en-
ergy metabolism is a major player in driving the onset and pro-
gression of several of these disorders; thus, a full understanding
of its strategic use of endogenous and exogenous energetic
sources is of mounting interest. In this context, the full compre-
hension of liver sexual differential activities is indispensable for
the generation of efficacious dietary and pharmacological inter-
ventions. Most of the studies carried out in the past have been
mainly devoted to a description of the even very significant differ-
ences in the two sexes, but failed to provide a clear understand-
ing of the biology that stands behind such differences.
We believe that the current study, by unraveling the major role
of aa in differentiatingmale and female liver metabolism provides
very important, new metabolic information to be exploited for
nutritional and medical purposes and puts a novel emphasis
on the importance of framing sexual dimorphisms in a broader
biological context, with the reproductive function acting as the
main element that, during evolution, induced the physiological
differences in male and female organisms.
Limitations of the Study
The full comprehension of liver sexual differential activities is
indispensable for the generation of efficacious dietary and phar-
macological interventions. Most of the studies carried out in the
past have been mainly devoted to a description of the even very
significant differences in the two sexes, but failed to provide a
clear understanding of the biology that stands behind such
differences.
A potential limitation of our study is that it was carried out in
mice, and further studies should be done in the future to demon-
strate that such sex-specific mechanisms are present in humans
too. However, considering the degree of evolutionary conserva-
tion of the mechanisms of reciprocal control between energy
metabolism and reproduction we believe that the current study,
by unraveling the major role of aa in differentiating male and fe-
male liver metabolism, provides very important, new metabolic
information to be exploited for nutritional and medical purposes.
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EXPERIMENTAL MODEL AND SUBJECT DETAILS
Animals
Control (ERa floxed), LERKO (Della Torre et al., 2011) and heterozygous ERE-Luc reporter (Ciana et al., 2001) mice were fed with
D12450B diet (Research Diets). Room temperature was maintained at 22C–25C and the light/dark cycle was 12 hr (lights on at
7:00 a.m.).
Unless otherwise stated, the mice were 8 months of age. Vaginal smears were performed at 9:00 a.m. To avoid any possible con-
founding effect due to the circadian rhythm or feeding status, the mice were euthanized in the early afternoon after 6 hr of fasting
(Della Torre et al., 2011).
ArKO mice were grown in D. Metzger animal facilities and tissues were collected as specified above.
For all the animal studies, both male and female mice were used.
All animal experimentation was performed in accordance with the ARRIVE guidelines and the European guidelines for animal care
and the use of experimental animals, approved by the Italian Ministry of Research and University, and controlled by a departmental
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Generation of ArKO Mice
The ArKO (aromatase KO) transgenic mouse was generated by homologous recombination in mouse C57BL/6 ESCs following stan-
dard procedure. Considering that the ATG translation start site of Cyp19a1 gene is located in coding exon II, the targeting vector
consists of reconstructed exon II of Cyp19a1 flanked by loxP sites, including 50 region of 4.2 kb and 30 region of 3.2 Kb to do the
homologous recombination. The targeting vector contains also the neomycin sequence flanked by FRT sites to allow the antibiotic
selection after the ESC electroporation. The presence of targeted insertion and absence of random integration in the ESC resistant
clones were identified using PCR analysis and later confirmed by Southern blotting. The PCR primers used were:
E-fwd GCTCTGGTCAGTTCTCCACAGAGGC;
N-rev GCGGCCGGAGAACCTGCGTGCAATC.
In this case the PCR product size of 4.7 Kb confirmed the presence of targeted integration.
L-fwd CGATAAGTGGACTTTTATTCCAGAC
L-rev GTGACTCACATATAGACTCCAGAAG
In this case the presence of transgene was confirmed by the PCR product size of 0.24 Kb, the absence of transgene by the PCR
product size of 0.19 Kb (WT).
Once identified the ESC clones positive for the targeted insertion, southern blotting confirms them. The genomic DNA extracted by
ES-positive clones was digested with PshAI restriction enzyme and the blot was incubated with NEO and 30EXT radiolabelled probes
(WT probe NEO: null; WT probe 30EXT: 10.9 Kb; TG probe NEO: 13 Kb; TG probe 30EXT: 13 Kb).
Then the genomic DNA extracted by ESC positive clones was digested with BglI restriction enzyme and the blot was incubated
with NEO and 50EXT radiolabeled probes (WT probe NEO: null; WT probe 50EXT: 16 Kb; TG probe NEO: 11.5 Kb; TG probe
50EXT: 6.2 Kb).
One positive ESC clone was injected into C57BL/6 blastocyst which are transferred to pseudo-pregnant CD-1 females. We ob-
tained chimeric male mice (with 80%–90% of chimerism) that were mated to wild-type (WT) C57BL/6 female mice to produce
F1 ArKO mice. The F1 ArKO mice were mated with Flp deleter transgenic mice (TACONIC) to remove ubiquitously the Neo cassette
producing the F2 ArKO mice. Then the ArKO F2 mice were mated with a cre-transgenic mouse strain for the ubiquitous deletion of
loxP-flanked gene segments to remove the ATG translation start site of Cyp19a1 gene producing the knockout of aromatase.
We confirmed the Cyp19a1 ablation by analyzing the expression of the aromatase gene by RTPCR in all the tissues received by
D. Metzger.
RNA-Sequencing Sample and Library Processing
RNA from liver of control (ERa floxed) and LERKO mice was isolated with TRIzol (Invitrogen) and purified using the RNeasy minikit
protocol (Qiagen), according to the manufacturer’s instructions.
RNA Quality Control was performed with the RNA 6000 Nano Kit (Agilent) on Agilent Bioanalyzer (Agilent). The RNA Integrity Num-
ber (RIN) was determined for every sample and all samples were considered suitable for processing if RIN > 7.5. RNA concentration
was spectrophotometrically estimated using Nanoquant Infinite M200 instrument (Tecan). Sequencing libraries were prepared using
the TruSeq RNA Sample Prep V2 (Illumina) with an input of 800 ng of total RNA. We validated and quantified final libraries with the
DNA1000 kit on Agilent Bioanalyzer. Pooled libraries were sequenced on Illumina NextSeq, producing 2X75 bp paired end reads.
Transcriptomics Data Analysis
Raw sequencing reads were processed for quality check using FASTQC (v0.11.5) (http://www.bioinformatics.babraham.ac.uk/
projects/fastqc/). Pre-alignment data processing, including trimming and adapter removal, was not performed as it not necessary
due to the high quality of data. Raw paired end reads (BioProject ID:PRJNA395963) were then mapped to the mouse reference
genome (GRCm38 primary assembly – gencode source) using STAR aligner (v2.5.2a) (Dobin et al., 2013) tuned accordingly to obtain
only uniquely mapped fragments. Gencode release M11 gene transfer file (GTF) was used as reference gene annotation file for align-
ment. Aligned data were manipulated using Samtools (Li et al., 2009) and several post-alignment quality control metrics were
collected using RNA-SeQC (DeLuca et al., 2012). In particular, we evaluated coverage across gene body, transcriptome profile ef-
ficiency (percentage of reads mapping to exons), samples correlation matrices and number of detected genes in order to identify
possible contaminations, mapping failures, and obvious outliers. We quantified gene expression by using the quantmode
GeneCounts option in STAR. The counts produced coincide with those produced by htseq-count (Anders et al., 2015) with
default parameters. Samples counts were merged into a single genes counts matrix (24 samples, 48709 genes – BioProject
ID:PRJNA395963), which was used as input for differential expression analysis. The statistical analysis was performed by using
DESeq2 package (Love et al., 2014), testing (Wald Test) group vs group accordingly to experimental design. Unless otherwise stated,
a threshold of 0.05 was applied to False Discovery Rate (FDR) adjusted p values in order to select the differentially expressed genes
(DEGs) to use in downstream analysis. Exploration data analysis (clustering and principal component analysis - PCA) was performed
using build in functions in DESeq2 package.
Venn diagram showing the number of DEGs inmouse liver wasmadewith Bioinformatics & Evolutionary Genomics software (http://
bioinformatics.psb.ugent.be/webtools/Venn/). Heatmap of DEGs was made with Shinyheatmap software by uploading the
quadruplicate mean values (Khomtchouk et al., 2017). Cluster analysis of functional networks significantly enriched in the liverCell Metabolism 28, 1–12.e1–e5, August 7, 2018 e3
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leading group term: highest significance. Gene ontology (GO) analysis on DEG lists was performed using the g:Profiler software (Re-
imand et al., 2016).
Metabolomic Analyses
Formetabolomic analyses, liver, muscle, white adipose tissue, testis, and ovary were homogenizedwith a tissue lyser. Briefly, tissues
were lysed in 250 mL of methanol/acetonitrile 1:1 (v/v) with D-Glucose-13C6 1 ng/mL (internal standard, Sigma Aldrich, 389374) and
centrifuged at 4C. Supernatant was saved for subsequent analysis. Amino acid quantification was performed through previous
derivatization. Samples were incubated with PITC solution for 20 min at RT, dried and resuspended in 5 mM ammonium acetate
in MeOH/H2O 1:1 (v/v).
Metabolomic data were performed on an API-4000 triple quadrupole mass spectrometer (AB SCIEX) coupled with a HPLC system
(Agilent) and CTC PAL HTS autosampler (PAL System). The identity of all metabolites was confirmed using pure standards. Quan-
tification of different metabolites was performed with a liquid chromatography/tandemmass spectrometry (LC-MS/MS) method us-
ing a C18 column (Biocrates) for amino acids and cyano-phase LUNA column (50 mm x 4.6 mm, 5 mm; Phenomenex). aa were
analyzed through a 10 min run in positive while other metabolites were run in negative ion mode in a 5 min run. 20 of multiple reaction
monitoring (MRM) transition in positive ion mode (aa) and 30 MRM transition in negative ion mode (all other metabolites) were used,
respectively. The mobile phases for positive ion mode analysis (aa) were phase A: 0.2% formic acid in water and phase B: 0.2% for-
mic acid in acetonitrile. The gradient was T0 100%A, T5.5min 5%A, T7min 100%Awith a flow rate of 500 mL/min. Themobile phase
for negative ion mode analysis (all other metabolites) was phase A: 5 mM ammonium acetate pH 7.00 in MeOH. The gradient was
100% A for all the analysis with a flow rate of 500 mL/min. MultiQuant software (version 3.0.2) was used for data analysis and
peak review of chromatograms. Quantitative evaluation of all metabolites was performed based on calibration curves with pure stan-
dards, then data were normalized onmicrograms of proteins. Metabolomic data analysis was performed by using Metaboanalyst 3.0
software (http://www.metaboanalyst.ca/).
Liver and Plasma Lipid Content
The free fatty acids (FFA), triglyceride (TG), and cholesterol (CH) levels were measured with appropriate kits according to the man-
ufacturer’s protocols (Biovision).
Pharmacological Treatments
Aromatase inhibition: vehicle or 1 mg/Kg/day Arimidex (Anastrazole, Sigma) were administered s.c. to the mothers starting from
pregnancy day 15 (PD15) until pup delivery. Pups were treated with vehicle or Arimidex 1 mg/Kg/day s.c. at the post-natal day 1
(P1) and then sacrificed after 3 hr.
Estrogen-induced masculinization: pups were treated with vehicle or 50 mg/Kg/day estradiol-benzoate (Sigma) s.c. at the post-
natal day 2, 5, and 8 (P2, P5 and P8) and then sacrificed at 8 months of age.
Luciferase Enzymatic Activity
Luciferase assay was carried out as previously described (Maggi and Rando, 2009). Briefly, freshly dissected tissues were immedi-
ately frozen and stored at80C for the biochemical assay. Tissues (20–100 mg) were homogenized by TissueLyser using 300 mL of
the phosphate lysis buffer (100 mM KPO4 pH 7.8, 1 mM dithiothreitol, 4 mM EGTA, 4 mM EDTA, and 0.7 mM PMSF) and stainless
steel beads in 1.2 mL polyethylene microtubes containing the tissue fragments or the cells.
Protein concentrations in the supernatants were measured using the Bradford assay using solutions and protocols commercially
available. The homogenates were frozen on dry ice and thawed in water, then are centrifuged (4900 g for 30 min at 4C). Supernatant
were collected and diluted to a protein concentration of 1 mg/mL. 20 mL of the supernatant is transferred to a white opaque 96-well
plate for luminescence quantification by luminometer (Glomax, Promega). Typically, luminescence is measured in an integration time
of 10 s, after automatically injecting 100 mL of luciferase assay reagent (10 mM luciferin, 1 M dithiothreitol, 200 mM ATP dissolved in
100 mM phosphate buffer, pH 7.0). Light measurements were recorded by the luminometer software. Luminescence data, normal-
ized over protein content of each sample, were finally expressed as relative light units (RLU) per mg of protein.
Real-Time PCR Gene Expression Analysis
Total liver RNA extraction was isolated with TRIzol Reagent (Invitrogen) and purified using the RNeasy minikit protocol (Qiagen), ac-
cording to themanufacturer’s instructions. For the preparation of cDNA, 1 mg RNAwas denatured at 75C for 5min in the presence of
1.5 mg of random primers (Promega) in 15 mL final volume. Deoxynucleotide triphosphate (GE Healthcare) and Moloney murine leu-
kemia virus reverse transcriptase (M-MLV RT) (Promega) were added at 0.5mm and 8U/mL final concentration, respectively, in a final
volume of 25 mL. The RT reaction was performed at 37C for 1 hr; the enzyme was inactivated at 75C for 5 min. Control reactions
without addition of the RT enzyme were performed for each sample.
For the real-time PCR experiments, the reactionmix for each sample wasmade up of 2 mL of pre-diluted cDNA, 5 mL of TaqMan 23
Universal PCR Master Mix No AmpErase UNG (ThermoFisher/Life Technologies), 0.5 mL of 20x primers/probes mix, and 2.5 mL ofe4 Cell Metabolism 28, 1–12.e1–e5, August 7, 2018
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50-GGCGACCTGGAAGTCCAACT-30 and reverse: 50-CCATCAGCACCACAGCCTTC-30). The reaction was carried out according to
the manufacturer’s protocol using QuantStudio 3 Real-Time PCR System with the following thermal profile: 2 min at 50C; 10 min
95C; 40 cycles (15 s at 95C, 1 min at 60C for Cyp19a1, Esr1 and Ar; 15 s at 95C, 1 min at 59C for 36b4), and data were analyzed
using the 2DDCt method (Livak and Schmittgen, 2001).
QUANTIFICATION AND STATISTICAL ANALYSIS
Statistical analyses were performed by Student’s t test for the comparison of two different experimental groups, or two-way ANOVA
followed by Bonferroni post hoc test for multiple testing comparisons. All statistical analyses were performed using GraphPad Prism
5.0 (GraphPad Software). All data are expressed asmean ± SEM. A p value less than 0.05 was considered statistically significant. The
statistical parameters can be found in the figure legends.
DATA AND SOFTWARE AVAILABILITY
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